41-50 of 303 results
Changes to Australia's IP laws are on the way
IP Australia has released draft legislation implementing the Federal Government's response to the Productivity Commission's inquiry into IP arrangements. ...
Fool's gold – how packaging can be misleading or deceptive
The Federal Court has ruled that adopting distinctive branding may not be enough to get a trader out of hot water if the get-up of the trader's products is similar to somebody else's. ...
Natasha Burns to join Allens as dedicated trade mark partner
Natasha joins Allens from her own firm, Burns IP, and will lead Allens' trade mark practice. She will be based in Melbourne. The appointment follows a number of years of growth and responds to clie ...
Beverage get-up round-up
Recent Federal Court beverage cases illustrate the challenges involved in protecting and enforcing secondary marks on food and beverage product packaging. ...
InIP: What's happening in intellectual property - December 2023
Your regular wrap-up of some of the world's leading and intriguing IP stories. ...
Where did you get those shoes? Manolo Blahnik seeks preliminary discovery against Estro Concept
Luxury shoe brand Manolo Blahnik sought preliminary discovery from designer outlet store Estro Concept (Estro) to determine whether it had a right to obtain relief for trade mark infringement and misleading conduct. ...
InIP: What's happening in intellectual property - November 2023
Your regular wrap-up of some of the world's leading and intriguing IP stories. ...
Allens advises Cigna on new health venture
The joint venture will aim to offer a range of services for the benefit of health fund members in Australia, to deliver better health outcomes and risk management. Each company will contribute $10 ...
InIP: What's happening in intellectual property - August 2023
Your regular wrap-up of some of the world's leading and intriguing IP stories. ...
Australian Government takes its $325 million damages claim to the High Court in Commonwealth v Sanofi
The Full Court has confirmed that the Australian Government is not entitled to any damages from Sanofi and Bristol-Myers Squibb. In this Insight, we examine the appeal decision and consider its implications for patent infringement proceedings relating to pharmaceutical products. ...